uniQure to Present at the Jefferies 2015 Global Healthcare Conference - London
November 12 2015 - 5:58AM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today
announced that its management will present at the Jefferies 2015
Global Healthcare Conference – London, to be held November 18-19,
2015.
Date: November 19, 2015
Time: 4:00 p.m. (GMT)
Speaking for uniQure: Jörn Aldag, Chief
Executive Officer
To access a simultaneous webcast of Mr. Aldag's presentation via
the internet, log on to the "Events" section on the Media page of
the uniQure website at
http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website
for 30 days following the conference. Mr. Aldag's presentation will
be available for download in PDF format immediately following the
conference presentation in the "Events" section of the Media page
of uniQure's website at
http://www.uniqure.com/news/calendar-of-events/.
About uniQure
uniQure is delivering on the promise of gene therapy – single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with CNS, liver/metabolic and cardiovascular diseases.
www.uniQure.com
CONTACT: uniQure:
Aicha Diba
Investor Relations
Direct : +31 20 240 6100
Main: +31 20 566 7394
a.diba@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024